Literature DB >> 19364859

In vitro activity of doripenem against Burkholderia pseudomallei.

Visanu Thamlikitkul1, Suwanna Trakulsomboon.   

Abstract

The MIC(50) and MIC(90) values of doripenem, determined by Etest, for 110 isolates of Burkholderia pseudomallei were 0.5 and 0.75 microg/ml, respectively. There were significant correlations between MICs determined by Etest and MICs determined by agar dilution, MICs determined by Etest and inhibition zone size, and MICs determined by agar dilution and inhibition zone size.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19364859      PMCID： PMC2704683          DOI： 10.1128/AAC.00893-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Antimicrobial resistance in Burkholderia pseudomallei.

Authors:  M Vorachit; P Chongtrakool; S Arkomsean; S Boonsong
Journal:  Acta Trop       Date:  2000-02-05       Impact factor: 3.112

2.  Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods.

Authors:  T J J Inglis; F Rodrigues; P Rigby; R Norton; B J Currie
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.

Authors:  F M Thibault; E Hernandez; D R Vidal; M Girardet; J-D Cavallo
Journal:  J Antimicrob Chemother       Date:  2004-10-27       Impact factor: 5.790

4.  Halving of mortality of severe melioidosis by ceftazidime.

Authors:  N J White; D A Dance; W Chaowagul; Y Wattanagoon; V Wuthiekanun; N Pitakwatchara
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

5.  Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.

Authors:  Vanaporn Wuthiekanun; Allen C Cheng; Wirongrong Chierakul; Premjit Amornchai; Direk Limmathurotsakul; Wipada Chaowagul; Andrew J H Simpson; Jennifer M Short; Gumphol Wongsuvan; Bina Maharjan; Nicholas J White; Sharon J Peacock
Journal:  J Antimicrob Chemother       Date:  2005-05-10       Impact factor: 5.790

6.  Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase.

Authors:  A J Godfrey; S Wong; D A Dance; W Chaowagul; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

7.  Comparison of imipenem and ceftazidime as therapy for severe melioidosis.

Authors:  A J Simpson; Y Suputtamongkol; M D Smith; B J Angus; A Rajanuwong; V Wuthiekanun; P A Howe; A L Walsh; W Chaowagul; N J White
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

8.  Outcomes of patients with melioidosis treated with meropenem.

Authors:  Allen C Cheng; Dale A Fisher; Nicholas M Anstey; Dianne P Stephens; Susan P Jacups; Bart J Currie
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 9.  Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens.

Authors:  Garyphallia Poulakou; Helen Giamarellou
Journal:  Expert Opin Investig Drugs       Date:  2008-05       Impact factor: 6.206

Review 10.  Melioidosis.

Authors:  N J White
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321
View more
  4 in total

1.  Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand.

Authors:  Vanaporn Wuthiekanun; Premjit Amornchai; Natnaree Saiprom; Narisara Chantratita; Wirongrong Chierakul; Gavin C K W Koh; Wipada Chaowagul; Nicholas P J Day; Direk Limmathurotsakul; Sharon J Peacock
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

2.  Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei.

Authors:  R S N Brilhante; L G A Valente; M F G Rocha; T J P G Bandeira; R A Cordeiro; R A C Lima; J J G Leite; J F Ribeiro; J F Pereira; D S C M Castelo-Branco; A J Monteiro; J J C Sidrim
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 3.  Treatment and prophylaxis of melioidosis.

Authors:  David Dance
Journal:  Int J Antimicrob Agents       Date:  2014-02-03       Impact factor: 5.283

Review 4.  The Treatment of Melioidosis.

Authors:  Timothy J J Inglis
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.